Breast Cancer
Conference Coverage
CTCs help predict breast cancer outcomes in neoadjuvant setting
SAN ANTONIO – Circulating tumor cells are a useful prognostic biomarker in early breast cancer patients treated with neoadjuvant chemotherapy,...
From the Journals
Neoadjuvant AI plus Ki67 info could deescalate adjuvant breast cancer treatment
Triage to chemotherapy based on a measurement of Ki67 proliferation after 2-4 weeks of neoadjuvant AI therapy for breast cancer is feasible and...
Conference Coverage
Gene, risk signatures could predict PARP inhibitor response in breast cancer
SAN ANTONIO – PARPi 7, BRCAness, and MammaPrint high1/(ultra)high2 signatures could help predict response to combination therapy with the PARP...
Original Report
Social support needs among patients with advanced breast cancer: sensitivity trumps substance
From the Journals
Counsel women against unnecessary prophylactic mastectomies
Women with breast cancer are much less likely to opt for contralateral prophylactic mastectomies if they know it won’t prolong their lives,...
Conference Coverage
SLND after neoadjuvant chemo is feasible, but more study needed
SAN ANTONIO – Sentinel lymph node detection after neoadjuvant chemotherapy (NAC) is a safe and feasible strategy for preventing unnecessary...
Conference Coverage
VIDEO: Watson helps oncologists sleuth out best options in breast cancer
SAN ANTONIO – Every day, practicing oncologists sort through mountains of data to make the best possible therapeutic decisions for their patients...
Conference Coverage
PIK3 inhibitor gives slight PFS edge at high cost for HR+/HER2– advanced breast cancer
SAN ANTONIO – A combination of a PI3K inhibitor and selective estrogen receptor down-regulator (SERD) met its primary endpoint of 2.1 months...
Conference Coverage
Cooling device reduces breast cancer–related alopecia during chemotherapy
SAN ANTONIO – About half of the women with stage 1 or 2 breast cancer who were treated using a scalp cooling device during chemotherapy retained...
Conference Coverage
VIDEO: AIs associated with endothelial dysfunction, a predictor of CVD
SAN ANTONIO – Aromatase inhibitors (AIs) appear to be associated with declines in vascular endothelial function, which in turn have been...
Conference Coverage
It’s elementary: Watson aids in breast cancer decisions
SAN ANTONIO – In this case, Watson is an artificial intelligence platform being developed in the United States and used in clinical practice in...